Stereotaxis Inc. (NYSE AMERICAN: STXS)
$2.11
+0.0950 ( +4.73% ) 314.0K
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States.
Market Data
Open
$2.11
Previous close
$2.01
Volume
314.0K
Market cap
$174.38M
Day range
$1.99 - $2.11
52 week range
$1.33 - $3.29
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jul 01, 2024 |
4 | Insider transactions | 1 | Jul 01, 2024 |
4 | Insider transactions | 1 | Jul 01, 2024 |
4 | Insider transactions | 1 | Jul 01, 2024 |
4 | Insider transactions | 1 | Jul 01, 2024 |
4 | Insider transactions | 1 | Jun 17, 2024 |
4 | Insider transactions | 1 | Jun 04, 2024 |
4 | Insider transactions | 1 | May 30, 2024 |
8-k | 8K-related | 14 | May 16, 2024 |
10-q | Quarterly Reports | 67 | May 15, 2024 |